Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serdal Ugurlu

Showing results (21-30 of 114) with videos related to

Pageof 12
Sort By:
Orphanet Journal of Rare Diseases|June 1, 2017
Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean feverSerdal Ugurlu, Aysa Hacioglu, Yasaman Adibnia, et al.
Rheumatology (Oxford, England)|February 17, 2026
Machine learning algorithms for predicting colchicine resistance in familial Mediterranean feverAdmir Öztürk, Berkay Kılıç, Murad Kucur, et al.
Rheumatology (Oxford, England)|May 22, 2024
Efficacy and safety of biologic drugs in Still's disease: a systematic review and network meta-analysis of randomized controlled trialsBerkay Kilic, Admir Ozturk, Sejla Karup, et al.
Expert Review of Clinical Immunology|December 22, 2023
The clinical role of anakinra in the armamentarium against familial Mediterranean feverKerem Parlar, Muhammed Bahaddin Ates, Bugra Han Egeli, et al.
Immunological Investigations|April 24, 2020
Soluble TREM-1 Levels in Familial Mediterranean Fever Related AA-AmyloidosisSerdal Ugurlu, Bugra Han Egeli, Ibrahim Murat Bolayirli, et al.
Modern Rheumatology|August 9, 2024
Severity scores, damage indices, and the concept of the colchicine-resistant patient in familial Mediterranean feverOzan Er, Helin Akay, Mehmet Emre Ozgozen, et al.
Rheumatology (Oxford, England)|June 20, 2020
Safety and efficacy of anti-interleukin-1 treatment in 40 patients, followed in a single centre, with AA amyloidosis secondary to familial Mediterranean feverSerdal Ugurlu, Bilgesu Ergezen, Bugra Han Egeli, et al.
Reumatologia Clinica|February 2, 2026
Impact of MEFV gene variants on clinical presentation in Familial Mediterranean Fever: A focus on Exon 2 mutationsBilal Kulaksiz, Beste Acar, Oguzhan Omer Kizilkaya, et al.
Rheumatology (Oxford, England)|December 9, 2020
Anakinra treatment in patients with familial Mediterranean fever: a single-centre experienceSerdal Ugurlu, Bilgesu Ergezen, Bugra Han Egeli, et al.
Reumatologia Clinica|April 15, 2023
When to start secukinumab treatment in patients with axial spondyloarthropathy: Before or after anti-TNFα treatment?Tumay Ak, Leyla Mustafayeva, Yeliz Celik, et al.
Pageof 12

Showing results (21-30 of 114) with videos related to

Sort By:
Pageof 12
Orphanet Journal of Rare Diseases|June 1, 2017
Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean feverSerdal Ugurlu, Aysa Hacioglu, Yasaman Adibnia, et al.
Rheumatology (Oxford, England)|February 17, 2026
Machine learning algorithms for predicting colchicine resistance in familial Mediterranean feverAdmir Öztürk, Berkay Kılıç, Murad Kucur, et al.
Rheumatology (Oxford, England)|May 22, 2024
Efficacy and safety of biologic drugs in Still's disease: a systematic review and network meta-analysis of randomized controlled trialsBerkay Kilic, Admir Ozturk, Sejla Karup, et al.
Expert Review of Clinical Immunology|December 22, 2023
The clinical role of anakinra in the armamentarium against familial Mediterranean feverKerem Parlar, Muhammed Bahaddin Ates, Bugra Han Egeli, et al.
Immunological Investigations|April 24, 2020
Soluble TREM-1 Levels in Familial Mediterranean Fever Related AA-AmyloidosisSerdal Ugurlu, Bugra Han Egeli, Ibrahim Murat Bolayirli, et al.
Modern Rheumatology|August 9, 2024
Severity scores, damage indices, and the concept of the colchicine-resistant patient in familial Mediterranean feverOzan Er, Helin Akay, Mehmet Emre Ozgozen, et al.
Rheumatology (Oxford, England)|June 20, 2020
Safety and efficacy of anti-interleukin-1 treatment in 40 patients, followed in a single centre, with AA amyloidosis secondary to familial Mediterranean feverSerdal Ugurlu, Bilgesu Ergezen, Bugra Han Egeli, et al.
Reumatologia Clinica|February 2, 2026
Impact of MEFV gene variants on clinical presentation in Familial Mediterranean Fever: A focus on Exon 2 mutationsBilal Kulaksiz, Beste Acar, Oguzhan Omer Kizilkaya, et al.
Rheumatology (Oxford, England)|December 9, 2020
Anakinra treatment in patients with familial Mediterranean fever: a single-centre experienceSerdal Ugurlu, Bilgesu Ergezen, Bugra Han Egeli, et al.
Reumatologia Clinica|April 15, 2023
When to start secukinumab treatment in patients with axial spondyloarthropathy: Before or after anti-TNFα treatment?Tumay Ak, Leyla Mustafayeva, Yeliz Celik, et al.
Pageof 12